logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
E

Emmanuel Deshayes

INSERM
H指数:23
被引数:2,081

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

[177Lu]Lu-DOTA-TATE plus long-acting octreotide in patients with newly diagnosed, advanced, grade 2–3, gastroenteropancreatic neuroendocrine tumours: preplanned and post-hoc efficacy analyses from the randomised, phase 3 NETTER-2 trial

[177Lu]Lu-DOTA-TATE联合长效奥曲肽治疗新诊断的、进展期、2-3级胃肠胰腺神经内分泌肿瘤患者的疗效分析：来自随机III期NETTER-2试验的预先计划和事后分析

EClinicalMedicine
IF10
2026-08-070
OA
Diego Ferone; Marianne Pavel; Ken Herrmann; Pamela L. Kunz; Sten Myrehaug; Daniel Halperin; Beth Chasen; Jaume Capdevila; Amparo García-Burillo; Salvatore Tafuto; Secondo Lastoria; Do-Youn Oh; Changhoon Yoo; Stephen Falk; Thorvardur R. Halfdanarson; Maddalena Sansovini; Laura Gerard; Emmanuel Deshayes; Angelina Filice; Ilya Folitar
[177Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial

[177Lu]Lu-edotreotide与依维莫司治疗胃肠胰神经内分泌肿瘤的比较（COMPETE研究）：一项III期、多中心、随机、开放标签、优效性试验

The Lancet
IF88.5
2026-07-020
PRE
Thomas Walter; Henning Jann; Catherine Ansquer; Emmanuel Deshayes; Rocio Garcia-Carbonero; Alexandre Teulé; Richard P Baum; Hein J Verberne; Jarosław B Ćwikła; Rajaventhan Srirajaskanthan; Louis de Mestier; Chiara M Grana; Andreas Buck; Dieter Hörsch; Marianne Pavel; Lawrence O Dierickx; Michael Michael; Jonathan Strosberg; Attila Kollár; Paula Jimenez-Fonseca
18F-Fluorodeoxyglucose PET-CT evaluation after one course of neoadjuvant therapy fails to predict pCR in HER2 + BC patients: a prospective and multicentric French study

18F-Fluorodeoxyglucose PET-CT评估在完成一周期新辅助治疗后无法预测HER2+BC患者的pCR：一项前瞻性、多中心法国研究

Breast Cancer Research
IF5.6
2025-12-030
OAAI
M. Chanchou; MA. Mouret–Reynier; I. Molnar; E. Deshayes; V. D’Hondt; K. Bourahla; T. Petit; S. Bardet; C. Levy; O. Morel; P. Augereau; C. Rousseau; M. Campone; J. Monteil; L. Venat–Bouvet; A. Faye; V. Benavent; F. Cachin
Generation Using Phage-Display of pH-Dependent Antibodies Against the Tumor-Associated Antigen AXL

通过噬菌体展示技术生成针对肿瘤相关抗原AXL的pH依赖性抗体

Antibodies 2025, Vol. 14, Page 83
IF2.7
2025-10-010
OAAI
Tristan Mangeat; Célestine Mairaville; Myriam Chentouf; Madeline Neiveyans; Martine Pugnière; Giang Ngo; Vincent Denis; Corentin Catherine; Alexandre Pichard; Emmanuel Deshayes; Margaux Maurel; Matthieu Gracia; Anne Bigot; Vincent Mouly; Sébastien Estaran; Alain Chavanieu; Pierre Martineau; Bruno Robert
Regorafenib plus modified gemcitabine-oxaliplatin in patients with advanced biliary tract cancer. The randomized phase Ib/II BREGO study

瑞戈非尼联合改良吉西他滨-奥沙利铂方案治疗晚期胆道癌。BREGO研究（随机 Ib/II 期）。

ONCOLOGIST
IF4.2
2025-06-010
OAAI
Blanc, Jean-Frederic; Bouattour, Mohamed; Gauthier, Ludovic; Deshayes, Emmanuel; Guillemard, Sophie; Touchefeu, Yann; Portales, Fabienne; Borg, Christophe; Harguem, Lobna; Guimbaud, Rosine; Mineur, Laurent; Ychou, Marc; Mazard, Thibault; Assenat, Eric
A Randomized clinical trial evaluating the impact on survival and quality of life of 177Lutetium[Lu]-edotreotide versus everolimus in patients with neuroendocrine tumors of the lung and thymus: the LEVEL study (GETNE T-2217)
BMC CANCER
IF3.4
2025-04-040
OAAI
Capdevila, Jaume; Pubul, Virginia; Anido, Urbano; Walter, Thomas; Molina-Cerrillo, Javier; Alonso-Gordoa, Teresa; Garcia-Carbonero, Rocio; San-Roman-Gil, Maria; Llana, Belen; Jimenez-Fonseca, Paula; Benavent Vinuales, Marta; Ansquer, Catherine; Baudin, Eric; Lepage, Come; del Olmo-Garcia, Maribel; Ruffinelli, Jose Carlos; Beron, Amandine; Haissaguerre, Magalie; Deshayes, Emmanuel; Taieb, David; Baldari, Sergio; Sansovini, Maddalena; Cingarlini, Sara; Filice, Angelina; Panzuto, Francesco; Alvarez-Alvarez, Rosa; Lousberg, Laurence; Aboubakar Nana, Frank; Hernando, Jorge; Garcia-Alvarez, Alejando; Garcia-Burillo, Amparo; Villacampa, Guillermo; Vandamme, Timon; Fazio, Nicola; Durand, Alice
Absorbed Dose - Response Relationship in Patients with Gastroenteropancreatic Neuroendocrine Tumors Treated with [ 177 Lu]Lu-DOTATATE: One Step Closer to Personalized Medicine

[177 Lu] lu-dotatate治疗胃肠胰神经内分泌肿瘤患者的吸收剂量-反应关系: 向个性化药物迈进了一步

JOURNAL OF NUCLEAR MEDICINE
IF9.1
2024-04-186
OAAI
Hebert, Kevin; Santoro, Lore; Monnier, Maeva; Castan, Florence; Berkane, Ikrame; Assenat, Eric; Fersing, Cyril; Gelibert, Pauline; Pouget, Jean-Pierre; Bardies, Manuel; Kotzki, Pierre -Olivier; Deshayes, Emmanuel

研究方向

暂未获取到该数据
L
Lore Santoro
H 指数:12论文数:57被引数:606
C
Cyril Fersing
H 指数:12论文数:67被引数:483
B
Boris Guiu
H 指数:55论文数:449被引数:1.3万
M
Manuel Bardiès
H 指数:44论文数:275被引数:8,570
J
Jean‐Pierre Pouget
H 指数:34论文数:160被引数:5,371
A
Alexandre Pichard
H 指数:13论文数:54被引数:488
S
Sophie Guillemard
H 指数:5论文数:18被引数:138
P
Pierre‐Olivier Kotzki
H 指数:16论文数:49被引数:943
J
John O. Prior
H 指数:54论文数:591被引数:1.1万
M
Marie‐Claude Eberlé
H 指数:7论文数:35被引数:412